Thromboembolism in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer

被引：17
作者：
Alexander, Marliese [1 ,2 ]
Solomon, Benjamin [3 ,4 ]
Burbury, Kate [5 ]
机构：
[1] Peter MacCallum Canc Ctr, Pharm Dept, Melbourne, Vic, Australia
[2] Monash Univ, Dept Epidemiol & Preventat Med, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[4] Univ Parkville, Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[5] Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia
来源：
CLINICAL LUNG CANCER | 2018年 / 19卷 / 01期
关键词：
Anaplastic lymphoma kinase; Deep vein thrombosis; Non small cell lung cancer; Pulmonary embolism; Thromboembolism; VENOUS THROMBOEMBOLISM; RISK; CHEMOTHERAPY; PREDICT; VTE;
D O I：
10.1016/j.cllc.2017.07.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E71 / E72
页数：2
相关论文
共 15 条
[1]   D-Dimer, fibrinogen and TEG-MA predict thromboembolism in non-small cell lung cancer - interim results from a prospective cohort study [J].
Alexander, M. ;
Wolfe, R. ;
Ball, D. ;
Manser, R. ;
McManus, M. ;
Riedel, B. ;
Solomon, B. ;
Westerman, D. ;
Burbury, K. .
THROMBOSIS RESEARCH, 2016, 140 :S170-S170
[2]   Thromboembolism in lung cancer - An area of urgent unmet need [J].
Alexander, M. ;
Kirsa, S. ;
Wolfe, R. ;
MacManus, M. ;
Ball, D. ;
Solomon, B. ;
Burbury, K. .
LUNG CANCER, 2014, 84 (03) :275-280
[3]   Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer [J].
Alexander, Marliese ;
Wolfe, Rory ;
Ball, David ;
Conron, Matthew ;
Stirling, Robert G. ;
Solomon, Benjamin ;
MacManus, Michael ;
Officer, Ann ;
Karnam, Sameer ;
Burbury, Kate ;
Evans, Sue M. .
BRITISH JOURNAL OF CANCER, 2017, 117 (05) :744-751
[4]   The Incidence and Outcome of Venous Thrombo-Embolism (VTE) In Non-Small Cell Lung Cancer Patients with Adenocarcinoma Histology In Comparison with Squamous Histology [J].
Bhat, Ashwini ;
Surapaneni, Rakesh ;
Hageboutros, Alexandre ;
Milcarek, Barry ;
Hunter, Krystal ;
Coakley, Susan ;
Ferber, Andres .
BLOOD, 2010, 116 (21) :1715-1715
[5]  
Davidsson E, 2017, MULTIDISCIP RESP MED, V12, DOI 10.1186/s40248-017-0097-0
[6]   Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial [J].
Gettinger, Scott N. ;
Bazhenova, Lyudmila A. ;
Langer, Corey J. ;
Salgia, Ravi ;
Gold, Kathryn A. ;
Rosell, Rafael ;
Shaw, Alice T. ;
Weiss, Glen J. ;
Tugnait, Meera ;
Narasimhan, Narayana I. ;
Dorer, David J. ;
Kerstein, David ;
Rivera, Victor M. ;
Clackson, Timothy ;
Haluska, Frank G. ;
Camidge, David Ross .
LANCET ONCOLOGY, 2016, 17 (12) :1683-1696
[7]   Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States [J].
Khorana, Alok A. ;
Dalal, Mehul ;
Lin, Jay ;
Connolly, Gregory C. .
CANCER, 2013, 119 (03) :648-655
[8]   Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer [J].
Lee, Yun-Gyoo ;
Kim, Inho ;
Lee, Eunyoung ;
Bang, Soo-Mee ;
Kang, Chang Hyun ;
Kim, Young Tae ;
Kim, Hak Jae ;
Wu, Hong-Gyun ;
Kim, Young Whan ;
Kim, Tae Min ;
Lee, Keun-Wook ;
Lee, Se-Hoon ;
Kim, Dong-Wan ;
Heo, Dae Seog .
THROMBOSIS AND HAEMOSTASIS, 2014, 111 (06) :1112-1120
[9]   Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial [J].
Shaw, Alice T. ;
Gandhi, Leena ;
Gadgeel, Shirish ;
Riely, Gregory J. ;
Cetnar, Jeremy ;
West, Howard ;
Camidge, D. Ross ;
Socinski, Mark A. ;
Chiappori, Alberto ;
Mekhail, Tarek ;
Chao, Bo H. ;
Borghaei, Hossein ;
Gold, Kathryn A. ;
Zeaiter, Ali ;
Bordogna, Walter ;
Balas, Bogdana ;
Puig, Oscar ;
Henschel, Volkmar ;
Ou, Sai-Hong Ignatius .
LANCET ONCOLOGY, 2016, 17 (02) :234-242
[10]  
Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI [10.1056/NEJMoa1311107, 10.1056/NEJMc1404894]
12